Brady (BRC) Q4 2026 Earnings Call Transcript

Brady reported fiscal Q4 sales of $436.9 million, up 10.0% year over year, and adjusted EPS of $1.48, up 17.5%, as gross margin expanded 250bps to 52.9%; excluding a $4 million tariff refund and prior-year closure costs, gross margin rose 110bps. Full-year adjusted EPS reached a sixth consecutive record at $5.29, up 15.0%, while operating cash flow increased nearly 35% to $244.1 million. Following the Aug. 3 acquisition of Honeywell's Productivity Solutions and Services business, Brady guided fiscal 2027 adjusted EPS to $6.25-$6.75, implying 18.1%-27.6% growth and including roughly $0.80 of IPS accretion, primarily in the second half. Risks include memory supply and cost pressures, higher electronics and diesel costs, integration execution, and weak European manufacturing demand.

Analysis

BRC's near-term rerating case rests on investors underwriting the acquired IPS earnings stream at Brady's historically higher-quality multiple. That is not yet warranted: the initial IPS margin profile is materially below legacy IDS, while adjusted EPS excludes acquisition-related integration costs and amortization whose magnitude will only be disclosed after purchase-price accounting. The first clean test is fiscal Q2-Q3: IPS must demonstrate stable gross margin despite memory and freight inflation, with working-capital conversion intact as the business scales through VAR channels.

The more durable upside is the installed-base flywheel. IDS printer placements pull through proprietary consumables, while IPS scanners/mobile devices can add software and service revenue; successful cross-selling would raise recurring revenue mix and reduce cyclicality versus standalone industrial labeling. ZBRA is the clearest public competitive read-through: BRC's combination of print, scan, RFID and software could pressure Zebra's channel economics in selected warehouse, healthcare and manufacturing accounts, although BRC remains unlikely to disrupt Zebra's enterprise incumbency quickly.

Consensus is likely to focus on the guided EPS accretion, but the key risk/reward is execution timing rather than headline growth. With most accretion deferred to the second half, a modest systems-integration delay, memory-cost pass-through failure, or weak European industrial demand can create a first-half estimate-reset window. Conversely, evidence that IPS revenue exceeds low-single-digit growth while segment margin holds in the low-double-digits would validate that guidance was conservatively framed and support multiple expansion over the next 6-18 months.

The data-center wire-ID exposure is a useful demand indicator but should not be treated as an AI infrastructure proxy at the same valuation as semiconductors or server OEMs. Its revenue sensitivity is tied more to construction and fit-out activity than GPU procurement; a pause in hyperscale capex would affect BRC later in the build cycle, potentially after NVDA demand signals have already weakened.

Key Decisions for Investors

• Establish a 1-3 month BRC watch-to-buy around the first fiscal 2027 report rather than chase initial optimism. Upgrade to a long only if IPS revenue is at or above its low-single-digit growth plan, gross margin is not eroding from memory costs, and management quantifies amortization/integration expense; these are the missing inputs for a clean earnings-quality assessment.
• If BRC trades at a material premium to its pre-acquisition industrial peer valuation before Q2, consider a tactical short or underweight through the first-half integration period. Thesis invalidation: IPS margin holds or improves sequentially and management pulls forward the second-half accretion cadence.
• Monitor ZBRA as a competitive hedge/read-through over 6-18 months: a long BRC / short ZBRA pair is only actionable if BRC reports measurable enterprise cross-sell wins or recurring software attach gains while ZBRA's bookings or gross margin weaken. Without disclosed channel-share data, this remains an alert rather than a recommendation.
• Do not use HON as a direct post-close beneficiary trade; its exposure is limited to transaction proceeds and capital allocation rather than ongoing IPS operating performance. Focus instead on BRC's net-leverage trajectory: failure to move below 2x within two years would constrain buybacks and compress the acquisition-driven rerating.